NATURAL HEALTH TRENDS CORP
10QSB, 1996-11-15
EDUCATIONAL SERVICES
Previous: NATURAL HEALTH TRENDS CORP, NT 10-Q, 1996-11-15
Next: AMERICAN TOYS INC, NT 10-Q, 1996-11-15



                                   FORM 10-QSB
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

[X]      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
         SECURITIES EXCHANGE ACT OF 1934

                    For the Quarter Ended September 30, 1996

[  ]     TRANSITION REPORT PURSUANT TO 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

           For the transition period from ____________ to ____________

                         Commission file number 0-25238

                           NATURAL HEALTH TRENDS CORP.
        (Exact name of Small Business Issuer as specified in its charter)


        Florida                                         59-2705336
(State or other jurisdiction of            (I.R.S. Employer Identification No.)
 incorporation or organization)

                        2001 West Sample Road, Suite 318
                             Pompano Beach, FL 33064
                    (Address of Principal Executive Offices)

                                 (954) 969-9771
                           (Issuer's telephone number)


         Check whether the issuer: (1) filed all reports required to be filed by
Section 13 or 15(d) of the  Securities  Exchange  Act of 1934 during the past 12
months (or for such shorter period that the registrant was required to file such
reports),  and (2) has been subject to such filing  requirements for the past 90
days.

                  Yes    X                      No

         The number of shares  outstanding of the issuer's  Common Stock,  $.001
par value, as of November 14, 1996 was 11,195,108 shares.


<PAGE>



                           NATURAL HEALTH TRENDS CORP.


                                      INDEX

<TABLE>
<CAPTION>


                                                                                         Page
                                                                                        Number
<S>                                                                                      <C>

PART I - FINANCIAL INFORMATION
        ITEM 1.           FINANCIAL STATEMENTS
                          Consolidated Balance Sheet as of September 30, 1996             1
                          (unaudited)
                          Consolidated Statements of Operations (unaudited) for the
                          Three and Nine months ended September 30, 1996 and              2
                          1995
                          Consolidated Statements of Cash Flows (unaudited) for the
                          Nine months ended September 30, 1996 and 1995                   3

                          Notes to the financial statements                               4-6
         ITEM 2.          MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                          FINANCIAL CONDITION AND RESULTS OF
                          OPERATIONS                                                      7-10

PART II - OTHER INFORMATION                                                              11-13
        ITEM 5.           OTHER INFORMATION
        ITEM 6.           EXHIBITS AND REPORTS ON FORM 8-K

SIGNATURE                                                                                14


</TABLE>

<PAGE>


                           NATURAL HEALTH TRENDS CORP.

                           CONSOLIDATED BALANCE SHEET

                               SEPTEMBER 30, 1996

                                   (UNAUDITED)





                                     ASSETS

CURRENT ASSETS:
     Cash                                                 $             118,558
     Marketable securities                                              255,714
     Accounts receivable                                              1,389,076
     Inventories                                                        224,428
     Due from officers                                                  147,770
     Prepaid expenses and other current assets                          228,702
                                                            --------------------
         TOTAL CURRENT ASSETS                                         2,364,247

PROPERTY, PLANT AND EQUIPMENT                                         3,137,838
DUE FROM OFFICERS                                                        22,524
GOODWILL                                                              1,518,640
DEPOSITS AND OTHER ASSETS                                                86,754
                                                            --------------------

                                                          $           7,130,003
                                                            ====================


                      LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
     Accounts payable                                     $             355,931
     Accrued expenses                                                   158,612
     Revolving credit lines                                             505,465
     Notes payable                                                      125,000
     Current portion of long term debt                                   48,083
     Deferred revenue                                                   686,402
     Other current liabilities                                          144,803
                                                            --------------------
         TOTAL CURRENT LIABILITIES                                    2,024,295
                                                            --------------------

LONG-TERM DEBT                                                        1,910,750

DUE TO BANK                                                              43,491

COMMON STOCK SUBJECT TO PUT                                             380,000

STOCKHOLDERS' EQUITY:
     Preferred stock, $.001 par value, 1,500,000 shares 
         authorized; no shares issued and outstanding                        - 
     Common stock, $.001 par value; 20,000,000 shares 
        authorized; 11,189,108 shares issued and 
        outstanding at September 30, 1996                                11,189
     Additional paid-in capital                                       5,481,930
     Retained earnings (accumulated deficit)                         (2,341,652)
     Common stock subject to put                                       (380,000)
                                                            --------------------
         TOTAL STOCKHOLDERS' EQUITY                                   2,771,467
                                                            --------------------

                                                          $           7,130,003
                                                            ====================



                       See notes to consolidated financial
                                  statements.

                                        1
<PAGE>

                           NATURAL HEALTH TRENDS CORP.

                      CONSOLIDATED STATEMENTS OF OPERATIONS

                                   (UNAUDITED)
<TABLE>
<CAPTION>

                                                             Three months ended                   Nine months ended
                                                                September 30,                        September 30,
                                                    -------------------------------------------------------------------------
                                                         1996               1995               1996               1995
                                                    ---------------    ----------------   ----------------   ----------------
<S>                                                <C>                <C>                <C>                <C>   

REVENUES                                           $      1,791,214   $       1,077,356  $       5,461,644  $       2,981,326

COST OF SALES                                               834,775             493,473          2,925,645          1,467,643
                                                    ---------------    ----------------   ----------------   ----------------

GROSS PROFIT                                                956,439             583,883          2,535,999          1,513,683

SELLING, GENERAL AND
     ADMINISTRATIVE EXPENSES                              1,109,585             874,116          2,928,705          1,812,658

NON-CASH IMPUTED COMPENSATION EXPENSE                             -                   -                  -            559,000
                                                    ---------------    ----------------   ----------------   ----------------

OPERATING INCOME (LOSS)                                    (153,146)           (290,233)          (392,706)          (857,975)

OTHER INCOME (EXPENSE):
     Interest (net)                                         (55,952)            (55,800)          (161,578)          (112,320)
     Write-off of deferred financing costs                        -                   -                  -           (347,974)
                                                    ---------------    ----------------   ----------------   ----------------
         TOTAL OTHER INCOME (EXPENSE)                       (55,952)            (55,800)          (161,578)          (460,294)
                                                    ---------------    ----------------   ----------------   ----------------

INCOME (LOSS) BEFORE INCOME TAXES                          (209,098)           (346,033)          (554,284)        (1,318,269)

PROVISION FOR INCOME TAXES                                        -                   -                  -              5,000
                                                    ---------------    ----------------   ----------------   ----------------

NET INCOME (LOSS)                                  $       (209,098)  $        (346,033) $        (554,284) $      (1,323,269)
                                                    ===============    ================   ================   ================

EARNINGS (LOSS) PER COMMON SHARE                   $          (0.02)  $           (0.03) $           (0.05) $           (0.14)
                                                    ===============    ================   ================   ================

WEIGHTED AVERAGE COMMON SHARES USED                      11,189,108          10,673,262         11,159,665          9,185,912
                                                    ===============    ================   ================   ================


</TABLE>


















                            See notes to consolidated
                             financial statements.

                                        2
<PAGE>

                           NATURAL HEALTH TRENDS CORP.

                      CONSOLIDATED STATEMENTS OF CASH FLOWS

                                   (UNAUDITED)
<TABLE>
<CAPTION>

                                                                                                 Nine months ended
                                                                                                   September 30,
                                                                                         -----------------------------------
                                                                                              1996                1995
                                                                                         ----------------    ---------------
<S>                                                                                    <C>                  <C>   

CASH FLOWS FROM OPERATING ACTIVITIES:
     Net loss                                                                          $        (554,284)  $     (1,323,269)
                                                                                         ----------------    ---------------
     Adjustments  to  reconcile  net loss to net  cash  provided  by  (used  in)
         operating activities:
         Depreciation and amortization                                                           180,988             54,160
         Non-cash imputed compensation expense                                                         -            559,000
         Write-off of imputed deferred financing costs                                                 -            227,293

     Changes in assets and liabilities:
         (Increase) decrease in accounts receivable                                             (615,032)          (321,830)
         (Increase) decrease in inventories                                                      (99,541)            (1,224)
         (Increase) decrease in prepaid expenses                                                  38,544            (27,804)
         (Increase) decrease in deferred registration costs                                            -            165,421
         (Increase) decrease in deposits and other assets                                         (3,325)          (182,898)
         Increase (decrease) in accounts payable                                                 136,706            128,666
         Increase (decrease) in accrued expenses                                                  97,634             54,852
         Increase (decrease) in deferred revenue                                                 201,158             89,377
         Increase (decrease) in deferred taxes                                                         -              5,000
         Increase (decrease) in other current liabilities                                         68,512             56,184
                                                                                         ----------------    ---------------
            TOTAL ADJUSTMENTS                                                                      5,643            806,197
                                                                                         ----------------    ---------------

NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES                                             (548,641)          (517,072)
                                                                                         ----------------    ---------------

CASH FLOWS FROM INVESTING ACTIVITIES:
     Capital expenditures                                                                       (433,228)        (2,692,023)
     Acquisition expenses                                                                        (20,000)                 -
     Purchase of marketable securities                                                          (255,714)                 -
                                                                                         ----------------    ---------------

NET CASH USED IN INVESTING ACTIVITIES                                                           (708,942)        (2,692,023)
                                                                                         ----------------    ---------------

CASH FLOWS FROM FINANCING ACTIVITIES:
     Increase in due from officer                                                                (22,728)            (6,800)
     Proceeds from mortgage payable                                                                    -          1,875,000
     Increase (decrease) in due to bank                                                           16,188                  -
     Proceeds from notes payable and long-term debt                                              780,465            570,000
     Payments of notes payable and long-term debt                                               (208,427)          (761,917)
     Payment of dividends                                                                       (184,173)                 -
     Issuance of common stock                                                                          -          2,752,090
                                                                                         ----------------    ---------------

NET CASH PROVIDED BY FINANCING ACTIVITIES                                                        381,325          4,428,373
                                                                                         ----------------    ---------------

NET INCREASE (DECREASE) IN CASH                                                                 (876,258)         1,219,278

CASH, BEGINNING OF PERIOD                                                                        994,816             57,805
                                                                                         ----------------    ---------------

CASH, END OF PERIOD                                                                    $         118,558   $      1,277,083
                                                                                         ================    ===============
</TABLE>



                       See notes to consolidated financial
                                  statements.

                                        3
<PAGE>




                           NATURAL HEALTH TRENDS CORP.

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

                      NINE MONTHS ENDED SEPTEMBER 30, 1996

                                   (UNAUDITED)


1.       BASIS OF PRESENTATION

                  The  accompanying  financial  statements  are  unaudited,  but
         reflect  all  adjustments  which,  in the  opinion of  management,  are
         necessary for a fair presentation of financial position and the results
         of operations for the interim periods  presented.  All such adjustments
         are of a normal and recurring nature. The results of operations for any
         interim period are not necessarily indicative of the results attainable
         for a full fiscal year.

2.       EARNINGS (LOSS) PER SHARE

                  Per  share  information  is  computed  based  on the  weighted
         average number of shares outstanding during the period.

3.       REVOLVING CREDIT LINES

A.   The Company  entered into a revolving  credit line with Merrill Lynch as of
     October 4, 1995 in the amount of $300,000.  This revolving  credit line was
     activated by the Company on February 29, 1996.  The  revolving  credit line
     expires on October 31,  1997,  at which time the Company is required to pay
     back any and all amounts borrowed under the revolving credit line. Interest
     accrues at the rate of prime plus 1%. As of September 30, 1996, the Company
     had approximately  $185,000 outstanding under this revolving credit line. A
     $250,000  investment  that the Company has with Merrill Lynch is restricted
     as security for any loans under this revolving credit line.

B.   In April 1996, the Company entered into a revolving  credit  agreement with
     Capital Bank. The agreement  provides for advances up to $350,000,  carries
     interest  at 7%  and  matures  in  April  1997.  A  total  of  $320,000  is
     outstanding under this agreement at September 30, 1996.

                                        4

<PAGE>



4.       ACQUISITIONS

A.   On January 22, 1996,  the Company  acquired all of the assets of Sam Lilly,
     Inc., an alternative  health care clinic, in exchange for 380,000 shares of
     the  Company's  common  stock.  The  acquisition  was  accounted  for  as a
     purchase. The net assets acquired totaled approximately $9,000. As a result
     of this  acquisition,  the Company  recorded  goodwill of $1,380,000.  This
     goodwill is being amortized over a period of 20 years.

B.   On June 26, 1996, the Company  acquired the Institute of Natural  Medicine,
     Inc.,  an  alternative  health  care  clinic,  in  a  business  combination
     accounted for as a pooling of interests.  The Company acquired 100% of this
     company  in  exchange  for  110,000   shares  of  its  common  stock.   The
     accompanying  financial  statements  have  been  restated  to  reflect  the
     combined companies for all periods presented.

     The  following  table  presents  a  breakdown  of amounts  included  in the
accompanying statements of operations attributable to each company:

<TABLE>
<CAPTION>

                                                 Three months ended                              Nine months ended
                                                    September 30,                                   September 30,
                                      ------------------------------------------      ------------------------------------------
                                            1996                    1995                   1996                     1995
                                      ------------------      ------------------      -----------------       ------------------
<S>                                   <C>                     <C>                     <C>                     <C>    

REVENUES:
Natural Health Trends Corp.           $        1,602,464      $          876,592      $       4,785,683       $        2,379,034
Institute of Natural Medicine                    188,750                 200,764                675,961                  602,292
                                      ------------------      ------------------      -----------------       ------------------
           Total                      $        1,791,214      $        1,077,356      $       5,461,644       $        2,981,326
                                      ==================      ==================      =================       ==================
NET INCOME (LOSS):
Natural Health Trends Corp.           $         (222,593)     $         (371,113)     $        (672,720)      $       (1,398,509)
Institute of Natural Medicine                     13,495                  25,080                118,436                   75,240
                                      ------------------      ------------------      -----------------       ------------------
          Total                       $         (209,098)     $         (346,033)     $        (554,284)      $      (1,323,269)
                                      ==================      ==================      =================       ==================

</TABLE>




                                        5

<PAGE>



5.       WARRANTS

                  On August 9, 1996,  the  Company  effected a 2:1 split of both
         its Class A and Class B Warrants. Each Class A Warrant now entitles the
         holder to purchase one share of Common  Stock for an exercise  price of
         $3.00.  Each Class B Warrant now  entitles  the holder to purchase  one
         share of Common  Stock for an exercise  price of $3.625.  Additionally,
         the  redemption  price of Class A Warrants  was  adjusted  to $.025 per
         warrant  and the  closing  bid price at which the Class A Warrants  are
         redeemable  was adjusted to $4.50 per share.  The  redemption  price of
         Class B Warrants  was adjusted to $.025 per warrant and the closing bid
         price at which the Class B Warrants  are  redeemable  was  adjusted  to
         $5.00 per share.



                                        6

<PAGE>




            ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                       CONDITION AND RESULTS OF OPERATIONS

The following  discussion  should be read in conjunction  with the  consolidated
financial statements and notes contained in Item 1 hereof.

On June 26, 1996, the Company acquired the Institute of Natural  Medicine,  Inc.
in a business combination  accounted for as a pooling of interest.  Accordingly,
previous financial  statements have been restated and the following  discussions
include  the  accounts  of the  Institute  of Natural  Medicine,  Inc.,  for all
periods.

                 THREE MONTHS ENDED SEPTEMBER 30, 1996 AND 1995

Revenues:

Total  revenues were  $1,791,214  for the three months ended  September  30,1996
compared to  $1,077,356  for the three months  ended  September  30, 1995.  This
represents an increase of $718,858 or 66%.

Management  believes that the increase is primarily  attributable to $359,759 in
fee revenue  provided  by the  alternative  health  care clinic  acquired by the
Company in January  1996,  a decrease in revenue  from the  Institute of Natural
Medicine, Inc. of $12,014, an increase in revenue of $283,144 from the Company's
Oviedo school which was acquired in November  1995,  $68,943 in tuition  revenue
from the  previously  existing  Lauderhill  and Miami  schools due to  increased
enrollment and increased  tuition rates,  and $75,644 in rental income which did
not commence until property in Pompano Beach,  Florida ( the "Pompano Property")
was acquired in May 1995.  Revenues from the Company's on campus bookstores were
$73,080 for the three months ended September 30, 1996 as compared to $75,516 for
the comparable period in 1995.

Cost of sales:

Cost of sales  for the  three  months  ended  September  30,1996  were  $834,775
compared to $493,473  for the  comparable  period last year.  Gross  profit as a
percentage  of revenues  was 53%  compared  with 54% for the three  months ended
September  30,1995.  Management  believes  that the  decrease  in  gross  profit
percentage is related to the change in mix of services  provided by the Company,
specifically  the  alternative  health care clinics  which have higher costs for
salaries and  products.  Additionally,  the cost  attributable  to the Company's

                                  
                                        7

<PAGE>



corporate  massage  service which is in the start-up  stage  contributed to this
decrease as there was minimal revenues from this segment of the business.

Selling, General and Administrative Expenses:

Selling,  general and  administrative  expenses  were  $1,109,585  for the three
months ended September 30,1996. This represents an increase of $235,469 over the
three months ended September 30,1995.  Management  believes that the increase is
primarily  due to the new  operations of the  alternative  health care clinic as
well as the Company's  Oviedo  school.  As a percentage of revenues,  these cost
were 62% as compared to 81% in the 1995 period.

Interest Expense

Interest  expense for the three months ended  September  30, 1996 was $55,952 as
compared to $55,800 for the comparable period of 1995.

Net Loss

For the  three  months  ended  September  30,  1996,  the net loss was  $209,098
compared to a net loss of $346,033  for the three  months  ended  September  30,
1995.   Management   believes  that  the  decrease  in  the  loss  is  primarily
attributable to the impact of the individual elements discussed above.

                  NINE MONTHS ENDED SEPTEMBER 30, 1996 AND 1995

Revenues:

Total  revenues  were  $5,461,644  for the nine months ended  September  30,1996
compared to  $2,981,326  for the nine months  ended  September  30,  1995.  This
represents an increase of $2,480,318 or 83%.

Management believes that the increase is primarily attributable to $1,201,277 in
fee revenue  provided  by the  alternative  health  care clinic  acquired by the
Company in January 1996,  $591,516  from the  Company's  Oviedo school which was
acquired in  November  1995,  $353,879 in  increased  tuition  revenue  from the
previously existing Lauderhill and Miami schools due to increased enrollment and
increased  tuition  rates,  and $108,501 in rental income which did not commence
until the Pompano Property was acquired in May 1995. Revenues from the Company's
on campus  bookstores were $251,822 for the nine months ended September 30, 1996
as compared to $131,138 for the 1995  comparable  period.  The Company  believes
that this  increase is  primarily  attributable  to  increased  enrollment,  the
addition of the Oviedo school and a wider array of products.


                                        8

<PAGE>



Cost of sales:

Cost of sales  for the nine  months  ended  September  30,1996  were  $2,925,645
compared to $1,467,643  for the comparable  period last year.  Gross profit as a
percentage  of revenues  was 46% for the nine months  ended  September  30, 1996
compared  with 50% for the  nine  months  ended  September  30,1995.  Management
believes the  decrease in gross  profit as a  percentage  of revenues in 1996 is
attributable  to there  being a change  in the mix of  services  offered  by the
Company,  specifically  the alternative  health care clinics,  which have higher
costs  for  salaries  and  products,  in  addition  to the  inclusion  of  costs
attributable to the Company's  corporate  massage  service,  which is still in a
start-up stage,  contributed to such decrease and has provided  minimal revenues
to date.

Selling, General and Administrative Expenses:

Selling, general and administrative expenses were $2,928,705 for the nine months
ended September 30,1996. This represents an increase of $1,116,047 over the nine
months ended September 30,1995.  The increase is primarily due new operations of
the alternative  health care clinic as well as the Company's Oviedo school. As a
percentage  of  revenues,  these cost were 54% in the 1996 period as compared to
61% in the 1995 period.

Non-cash Imputed Compensation Expense

During the nine months ended September  30,1995,  the Company expensed  $559,000
relating to the  issuance of 215,000  shares of the  Company's  common  stock to
certain officers and individuals  within twelve months of the Company's  initial
public offering of it's securities (the "Initial Public Offering").  Such amount
represents the assumed fair market value of the shares of common stock issued to
these individuals.

This non cash  expense  in the  second  quarter  of 1995  was  accompanied  by a
corresponding increase in the additional paid-in capital account and resulted in
no change to stockholder's equity.

Writeoff of Deferred Finance Costs

The writeoff of deferred  finance  costs during the nine months ended  September
30, 1995 in the amount of $347,974  represents  the remaining  deferred  finance
costs  relating to bridge  financing in the amount of $350,000  during the first
quarter of 1995 (the "Bridge  Financing")  and a non-cash  imputed  common stock
valuation charge relating to other lenders.


                                        9

<PAGE>



Interest Expense

Interest  expense for the nine months ended  September  30, 1996 was $161,578 as
compared to $112,320 for the comparable period of 1995.The increase is primarily
due to interest on the  mortgage of the Pompano  Property  which was acquired in
May 1995.

Net Loss

For the nine months ended September 30, 1996, the net loss was $554,284 compared
to a net loss of  $1,323,269  for the nine  months  ended  September  30,  1995.
Management  believes that the decrease in the loss is primarily  attributable to
the impact of the individual elements discussed above.

                         Liquidity and Capital Resources

The Company has funded its working capital and capital expenditures requirements
from cash provided through borrowings from individuals and institutions and from
the sale of the  Company's  securities  in a private  placement  and the Initial
Public  Offering.  The  Company's  primary  source of cash  receipts is from the
payments for tuition, fees and books revenue from the operation of the Company's
alternative health care clinics. The payments related to fees, tuition and books
were funded  primarily from student and parent  educational  loans and financial
aid under various Federal and state assistance  programs and, to a significantly
lesser extent, from student and parent resources.

At September 30,1996 the ratio of current assets to current liabilities was 1.17
to 1.0, and working capital was approximately $340,000.

Cash used in operations for the period ended September 30,1996 was approximately
$549,000, attributable primarily to the net loss of $554,000.

The Company  entered  into a  revolving  credit  line with  Merrill  Lynch as of
October  4, 1995 in the  amount of  $300,000.  This  revolving  credit  line was
activated by the Company on February 29, 1996. The revolving credit line expires
on October 31,  1997,  at which time the Company is required to pay back any and
all amounts  borrowed under the revolving  credit line.  Interest accrues at the
rate of prime plus 1%. As of September 30, 1996,  the Company had  approximately
$185,000  outstanding  under this revolving  credit line. A $250,000  investment
that the Company has with Merrill  Lynch is restricted as security for any loans
under this revolving credit line.

In April  1996,  the Company  entered  into a revolving  credit  agreement  with
Capital  Bank.  The  agreement  provides for  advances up to  $350,000,  carries
interest  at 7% and matures in April  1997.  A total of $320,000 is  outstanding
under this agreement at September 30, 1996.

Capital expenditures,  primarily related to construction for the preparation for
use of the Pompano Property, used approximately $433,000 of cash.

The Company  anticipates that its net cash flow together with available lines of
credit will be sufficient to finance the  Company's  operations  during the next
twelve months.






                                        10

<PAGE>
PART II - OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS - none
Item 2. CHANGES IN SECURITIES - none
Item 3. DEFAULTS UPON SENIOR SECURITIES - none
Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITIES HOLDER

     The Company  held an annual meeting of stockholders  on August 7, 1996. The
     selection of Feldman Radin & Co., P.C. to serve as independent auditors for
     the year ending December 31, 1996 by the Board of Directors was ratified by
     a stockholder  vote of  11,012,867  for, 0 against and 100  abstained.  The
     amendment of the Company's  certificate  of  incorporation  increasing  the
     number of authorized  shares of Common Stock from  20,000,000 to 40,000,000
     was approved by the stockholders by a vote of 11,012,867 for and 0 against.

Item 5. OTHER INFORMATION - none
Item 6. EXHIBITS AND REPORTS OF FORM 8-K
          a) Exhibit Index
          b) Reports on Form 8-K - none












                                       11
<PAGE>



                    NATURAL HEALTH TRENDS CORP. EXHIBIT INDEX


Number  Description of Exhibit
1.1     Form of Underwriting Agreement between the Company and Maidstone 
        Financial Inc. (the "Underwriter").*
3.1     Amended and Restated Certificate of Incorporation of the Company.*
3.2     Amended and Restated By-Laws of the Company.*
4.1     Specimen Certificate of the Company's Common Stock.*
4.2     Form of Class A Warrant.*
4.3     Form of Class B Warrant.*
4.4     Form of Warrant Agreement between the Company and Continental Stock 
        Transfer & Trust  Company.*
4.5     Form of Underwriter's Warrants.*
4.6     Form of Class A Warrants issued in the 1995 Bridge Financing.*
4.7     Form of Class B Warrants issued in the 1995 Bridge Financing.*
4.8     Form of Bridge Notes issued in the 1995 Bridge Financing.*
4.9     1994 Stock Option Plan.*
10.1    Form of Employment Agreement between the Company and  Neal R. Heller.*
10.2    Form of Employment Agreement between the Company and Elizabeth S. 
        Heller.*
10.3    Letter Agreement, dated December 27, 1993, between the Company and 
        Richard Schuman.*
10.4    Lease, dated April 29, 1993, between Florida Institute of Massage 
        Therapy, Inc., as tenant, and MICC Venture, as landlord, as amended.*
10.5    lease, dated April 10, 1991, between Florida Institute of Massage 
        Therapy, Inc., as tenant, and Superior Investment & Development 
        Corporation, as agent, for SIDCOR 50/50 Associates.*
10.6    Department of Education, Office of Postsecondary Education, Office of
        Student Financial Assistance Program Participation Agreement, 
        dated March 28, 1994, between the Company and the USDOE.*
10.7    Purchase and Sale Agreement between Merrick Venture Capital, Inc., as 
        seller, and the Company, as buyer.*
10.8    First Mortgage Loan Documents between the Company and Trans Florida Bank
        in connection with the purchase of the Pompano Property.*

                                       12

<PAGE>


Number  Description of Exhibit
10.9    Equity Credit Plan and Note, dated March   , 1994, among the Company, 
        F.I.M.T.E., Neal R. Heller, Elizabeth S. Heller and American Bank of 
        Hollywood.*
10.10   Form of Financial Consulting Agreement between the Company and 
        Maidstone.*
10.11   Intentionally omitted.
10.12   Agreement dated June 7, 1995 between Natural Health Trends Corp. and 
        Justin Real Estate Corp.*
10.13   Property Management Agreement dated June 7, 1995 between Natural Health
        Trends Corp. and Justin Real Estate Corp.*
10.14   Agreement and Plan of Reorganization by and among the Company, HWNC and 
        Sam Lilly Corp., dated as of January 22, 1996.
10.15   Employment Agreement between HWNC and Samantha Haimes dated January 22,
        1996.
10.16   Employment Agreement between HWNC and Leonard Haimes, M.D. dated January
        27, 1996.
10.17   Agreement by and among the Company, HWNC, Medical Service Consultants, 
        Inc., Diagnostic Services, Inc., Managenet, Inc. and KBM Consultants.
10.18   Employment Agreement between Health Wellness Nationwide Corp., Kaye 
        Lenzi and Natural Health Trends Corp.
16.1    Letter from Soule & Associates, P.A. on change in certifying accountant.
21.1    List of Subsidiaries.*
27.1    Financial Data Schedule.


*       Previously filed with the Company's Registration Statement No. 33-991184


                                       13

<PAGE>




                                   SIGNATURES


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.



                                                 NATURAL HEALTH TRENDS CORP.

                                           /S/Neal Heller___________________
                                   By:     Neal Heller
                                           President and Chief Executive Officer

Date:   November 15, 1996




                                       14


<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0000912061
<NAME>                        NATURAL HEALTH TRENDS CORP.
<MULTIPLIER>                                   1
<CURRENCY>                                     U.S.
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-1996
<PERIOD-START>                                 JAN-01-1996
<PERIOD-END>                                   SEP-30-1996
<EXCHANGE-RATE>                                1
<CASH>                                         118,558
<SECURITIES>                                   255,714
<RECEIVABLES>                                  1,389,076
<ALLOWANCES>                                   0
<INVENTORY>                                    224,428
<CURRENT-ASSETS>                               2,364,247
<PP&E>                                         3,457,431
<DEPRECIATION>                                 319,593
<TOTAL-ASSETS>                                 7,130,003
<CURRENT-LIABILITIES>                          2,024,295
<BONDS>                                        2,589,298
                          380,000
                                    0
<COMMON>                                       11,189
<OTHER-SE>                                     2,760,278
<TOTAL-LIABILITY-AND-EQUITY>                   7,130,003
<SALES>                                        0
<TOTAL-REVENUES>                               5,461,644
<CGS>                                          0
<TOTAL-COSTS>                                  2,925,644
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             161,578
<INCOME-PRETAX>                                (554,284)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (554,284)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (554,284)
<EPS-PRIMARY>                                  (.05)
<EPS-DILUTED>                                  0
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission